2017 Innovation Waivers: The Future is Right Around the Corner Webinar
Deborah Bachrach, Michael Kolber, and Joel Ario, Manatt Health Solutions
Section 1332 of the Affordable Care Act permits states to request innovation waivers from the Departments of Health and Human Services (HHS) and Treasury of certain ACA requirements, with waivers first effective in 2017. This waiver process has attracted some attention from thought leaders, but the states, the requesting parties on any waiver applications, have been focused on more pressing ACA implementation issues. That is changing as states begin to consider their longer term goals for health reform and specifically the opportunities afforded by section 1332 waivers.
In order to help states jump start their thinking about 1332 waivers, experts from Manatt Health Solutions presented the regulatory framework for those waivers and offered some examples that illustrate the broad range of potential waivers and the guardrails that ensure waivers continue to meet the goals of the ACA. This webinar addressed which ACA provisions are waivable, including the individual mandate, the employer mandate, essential health benefits, and exchange standards; how the coverage and fiscal guardrails might be applied by HHS and Treasury, which have yet to provide much guidance beyond a regulation that defines the waiver application process; and how 1332 waivers might be combined with Medicaid 1115 waivers to better achieve state goals across programs. The webinar slides can be found at the “download” button and a webinar recording can be found here.
This expert perspective reviews key considerations for states exploring Marketplace insurance subsidies and highlights the experiences in the five states that have established state-based subsidies that supplement the ACA’s premium tax credit and cost-sharing reductions.
The United States is in the midst of an unprecedented national effort to manufacture, distribute, and ultimately administer COVID-19 vaccines to all Americans. While the federal government is coordinating distribution of vaccines from manufacturers to states, individual states (and certain municipalities) are responsible for coordinating the various components of infrastructure and operational logistics needed to take the vaccine from federal distribution channels to the arms of Americans. This expert perspective outlines four recommendations for states to engage their managed care plans to assist in efforts to successfully and rapidly vaccinate the Medicaid population.